NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway
    
Yazarlar (11)
Arundhati Jana Türkiye
Nancy L Krett Türkiye
Grace Guzman Türkiye
Ahmer Khalid Türkiye
Prof. Dr. Özkan ÖZDEN Kafkas Üniversitesi, Türkiye
Jonas J Staudacher Türkiye
Jessica Bauer Türkiye
Seung Hyun Baik Türkiye
Timothy Carroll Türkiye
Cemal Yazici Türkiye
Barbara Jung Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı ONCOTARGET
Dergi ISSN 1949-2553 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 06-2017
Cilt / Sayı / Sayfa 8 / 23 / 37377–37393 DOI 10.18632/oncotarget.16343
Makale Linki http://www.oncotarget.com/abstract/16343
Özet
Colorectal cancer (CRC) remains a common and deadly cancer due to metastatic disease. Activin and TGFB (TGFβ) signaling are growth suppressive pathways that exert non-canonical pro-metastatic effects late in CRC carcinogenesis. We have recently shown that activin downregulates p21 via ubiquitination and degradation associated with enhanced cellular migration independent of SMADs. To investigate the mechanism of metastatic activin signaling, we examined activated NFkB signaling and activin ligand expression in CRC patient samples and found a strong correlation. We hypothesize that activation of the E3 ubiquitin ligase MDM2 by NFkB leads to p21 degradation in response to activin treatment. To dissect the link between activin and pro-carcinogenic NFkB signaling and downstream targets, we found that activin but not TGFB induced activation of NFkB leading to increased MDM2 ubiquitin ligase via PI3K. Further, overexpression of wild type p65 NFkB increased MDM2 expression while the NFkB inhibitors NEMO-binding domain (NBD) and Bay11-7082 blocked the activin-induced increase in MDM2. In conclusion, in colon cancer cell migration, activin utilizes NFkB to induce MDM2 activity leading to the degradation of p21 in a PI3K dependent mechanism. This provides new mechanistic knowledge linking activin and NFkB signaling in advanced colon cancer which is applicable to targeted therapeutic interventions.
Anahtar Kelimeler
activin | NF kappa B | colon cancer | MDM2 | migration